The combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is feasible and can be an option for relapsed/refractory multiple myeloma (Q33342020)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is feasible and can be an option for relapsed/refractory multiple myeloma |
scientific article |
Statements
1 reference
The combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is feasible and can be an option for relapsed/refractory multiple myeloma (English)
1 reference
Maria Isabel González-Fraile
1 reference
Magdalena Sierra
1 reference
Carlos López
1 reference
Marcos González
1 reference
Jesús Fernando San Miguel
1 reference
1 January 2002
1 reference
1 reference
Identifiers
1 reference